Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DEFLAZACORT vs DENOSUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DEFLAZACORT vs DENOSUMAB: Safety Overview

Metric DEFLAZACORT DENOSUMAB
Total FAERS Reports 3,831 148,941
Deaths Reported 149 19,354
Death Rate 3.9% 13.0%
Hospitalizations 592 17,749
Average Patient Age 25.7 yrs 71.2 yrs
% Female Patients 15.1% 84.9%
FDA Approval Date Apr 25, 2024 N/A
Manufacturer Cranbury Pharmaceuticals, LLC Organon LLC
Route ORAL SUBCUTANEOUS
Marketing Status Prescription Prescription